Dalia completed her BSc (Hons) and MSc studies in pharmacobiology and toxicology at the National Autonomous University of Mexico. She received two international scholarships to study a PhD at the University of Melbourne and completed her doctoral studies in molecular toxicology in 2017. In her PhD research project, she used a combination of proteomic and transcriptomic analyses to identify more than 200 potential proteins responsible for toxicity in jellyfish venoms and assessed their potency and toxicity using pharmacological assays. Following PhD completion, Dalia was appointed as a Research Officer in the Mangum Lab: Translational Proteomics. In this role, she has been involved in the operation and maintenance of a new mass spectrometry facility housed in the Department of Pharmacology and Therapeutics, as well as providing technical support and assistance to staff and students for the design and execution of mass spectrometry-based experiments. She is also part of collaborative projects to elucidate the proteomes of metastatic cancer samples, drug resistance mechanisms, peptide characterisation and development of diagnostic tools.
Department: Department of Pharmacology and Therapeutics Email: firstname.lastname@example.org Phone: 0435 489 067
Current Research Focus
Proteomics and therapeutic development
Field of Research Description 60109 Proteomics and Intermolecular Interactions (excl. Medical Proteomics 111502 Clinical Pharmacology and Therapeutics
- Protein biochemistry
- Molecular biology
- Mass spectrometry
- Pharmacology and toxicology
Looking to collaborate?